...
首页> 外文期刊>Mathematical research letters: MRL >Decellularization combined with enzymatic removal of N-linked glycans and residual DNA reduces inflammatory response and improves performance of porcine xenogeneic pulmonary heart valves in an ovine in vivo model
【24h】

Decellularization combined with enzymatic removal of N-linked glycans and residual DNA reduces inflammatory response and improves performance of porcine xenogeneic pulmonary heart valves in an ovine in vivo model

机译:结合酶促除去N-连接的聚糖和残留DNA的脱细胞化减少了炎症反应,并提高了体内模型中卵株猪的卵烯异基因肺心脏瓣膜的性能

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Limited availability of decellularized allogeneic heart valve substitutes restricts the clinical application thereof. Decellularized xenogeneic valves might constitute an attractive alternative; however, increased immunological hurdles have to be overcome. This study aims for the in vivo effect in sheep of decellularized porcine pulmonary heart valves (dpPHV) enzymatically treated for N-glycan and DNA removal. Methods dpPHV generated by nine different decelluarization methods were characterized in respect of DNA, hydroxyproline, GAGs, and SDS content. Orthotopic implantation in sheep for six months of five groups of dpPHV (n = 3 each; 3 different decellularization protocols w/o PNGase F and DNase I treatment) allowed the analysis of function and immunological reaction in the ovine host. Allogenic doPHV implantations (n = 3) from a previous study served as control. Results Among the decellularization procedures, Triton X-100 & SDS as well as trypsin & Triton X-100 resulted in highly efficient removal of cellular components, while the extracellular matrix remained intact. In vivo, the functional performance of dpPHV was comparable to that of allogeneic controls. Removal of N-linked glycans and DNA by enzymatic PNGase F and DNase I treatment had positive effects on the clinical performance of Triton X-100 & SDS dpPHV, whereas this treatment of trypsin & Triton X-100 dpPHV induced the lowest degree of inflammation of all tested xenogeneic implants. Conclusion Functional xenogeneic heart valve substitutes with a low immunologic load can be produced by decellularization combined with enzymatic removal of DNA and partial deglycosylation of dpPHV.
机译:背景技术脱细胞异化心脏瓣膜替代物的有限可用性限制了其临床应用。脱细胞的异聚阀可能构成有吸引力的替代方案;然而,必须克服增加的免疫障碍。本研究旨在酶促处理N-聚糖和DNA去除脱皮猪肺心脏瓣膜(DPPHV)中的体内效应。方法对九种不同的脱池化方法产生的DPPHV表征DNA,羟基脯氨酸,胶质和SDS含量。绵羊的原位植入六个月的五组DPPHV(每个N = 3; 3种不同的脱细胞化方案W / O Pngase F和DNase I治疗)允许在绵羊宿主中分析功能和免疫反应。来自前一项研究的同种异体脱酚植入(n = 3)作为对照。结果在脱细胞化程序中,Triton X-100和SDS以及胰蛋白酶和Triton X-100导致高效除去细胞组分,而细胞外基质保持完整。在体内,DPPHV的功能性能与同种异体对照的功能性能相当。通过酶促PNGASE F和DNase I处理除去N-连接的聚糖和DNA对Triton X-100和SDS DPPH的临床表现产生阳性作用,而这种胰蛋白酶和Triton X-100 dpphv的治疗诱导了最低程度的炎症所有测试的异种植入物。结论官能异化心脏瓣膜替代品具有低免疫载荷,可以通过脱细胞化与DNA的酶移除和DPPH的部分脱糖基化结合产生。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号